FIGURE 1
FROM:
Minocycline protects against permanent cerebral ischemia in wild type but not in matrix metalloprotease-9-deficient mice
Milla Koistinaho, Tarja M Malm, Mikko I Kettunen, Gundars Goldsteins, Sofie Starckx, Risto A Kauppinen, Ghislain Opdenakker and Jari Koistinaho
BACK TO ARTICLEFigure 1.

Minocycline protects against permanent focal ischemic damage. (A) Typical examples of TTC-stained brain sections showing ischemic lesions as white areas in saline and minocycline-treated FVB/N mice at 24 hours after the onset of MCA occlusion. The treatments were started 12 hours before ischemic insult. (B) Quantitative data of infarct volumes in saline and minocycline-treated FVB/N mice. Data are shown as mean
s.e.m. **
P
0.01, t-test; mino, minocycline.
